ReviewExpert review of clinical pharmacology2018

PD-1/PD-L1 pathway inhibitors in advanced prostate cancer.

Pedro Isaacsson Velho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.